{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:21:45Z","timestamp":1787638905672,"version":"build-2736575974"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Research shows immune dysregulation in bipolar disorder (BD), but clinical heterogeneity and variable treatment responses persist around inflammatory markers like IL-6, TNF-\u03b1, and CRP. Newly identified EBI3-containing cytokines (IL-27, IL-35, IL-39) can be proinflammatory or immunoregulatory\/putatively neuroprotective, and their role in BD remains unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Serum levels of EBI3-containing inflammatory cytokines (IL-27, IL-35, IL-39, and EBI3) and conventional inflammatory markers (CRP, TNF-\u03b1, IL-6, and IL-10) were measured in this case-control, observational study using a high-sensitivity enzyme-linked immunosorbent assay (ELISA) in a cohort of 60 patients with acute mania and 60 healthy controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with controls, patients with BD showed significantly higher serum levels of CRP (FDR-p = 0.008),  IL-6 (FDR-p = 0.004), IL-10 (FDR-p = 0.008), IL-27 (FDR-p = 0.008), and IL-35 (FDR-p = 0.0027). TNF-\u03b1 initially reached significance (p = 0.041) but did not remain significant after FDR correction (FDR-p = 0.0547). IL-39 (FDR-p = 0.473) and EBI3 (FDR-p = 0.713) showed no difference between patients and controls. These results highlight a pattern of heightened inflammatory and regulatory cytokine activity in BD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study suggests that IL-27 and IL-35 dysregulation characterizes the acute manic state of bipolar disorder and reflects a possible imbalance between pro- and anti-inflammatory responses. While these EBI3-containing cytokines may hold promise as state-related markers, their broader relevance across mood phases remains to be determined. Further longitudinal research is needed to evaluate state- versus trait-dependent immune alterations and their potential implications for personalized immunomodulation in BD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1759397","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:34:45Z","timestamp":1787636085000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Shifting the paradigm in bipolar disorder: moving beyond conventional inflammatory markers to novel EBI3-containing heterodimeric cytokines"],"prefix":"10.3389","volume":"17","author":[{"given":"Junfang","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Taiyuan Central Hospital, Peking University First Hospital Taiyuan Hospital","place":["Taiyuan, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixia","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Taiyuan Central Hospital, Peking University First Hospital Taiyuan Hospital","place":["Taiyuan, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Taiyuan Central Hospital, Peking University First Hospital Taiyuan Hospital","place":["Taiyuan, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chai","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Taiyuan Central Hospital, Peking University First Hospital Taiyuan Hospital","place":["Taiyuan, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Taiyuan Central Hospital, Peking University First Hospital Taiyuan Hospital","place":["Taiyuan, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/b978-1-4160-6643-9.00151-x","article-title":"Bipolar disorder","volume":"406","author":"Singh","year":"2025","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12423","article-title":"The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013","volume":"18","author":"Ferrari","year":"2016","journal-title":"Bipolar Disord"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-0831-4","article-title":"Advances toward precision medicine for bipolar disorder: mechanisms & molecules","volume":"26","author":"Haggarty","year":"2021","journal-title":"Mol Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00030","article-title":"Molecular mechanisms of bipolar disorder: progress made and future challenges","volume":"11","author":"Kim","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2014.00098","article-title":"Integrated neurobiology of bipolar disorder","volume":"5","author":"Maletic","year":"2014","journal-title":"Front Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105325","article-title":"Inflammation in bipolar disorder (BD): Identification of new therapeutic targets","volume":"163","author":"Pereira","year":"2020","journal-title":"Pharmacol Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/cei.13334","article-title":"The immune system and psychiatric disease: a basic science perspective","volume":"197","author":"Bennett","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nsa.2023.103923","article-title":"Breaking free from the inflammatory trap of depression: Regulating the interplay between immune activation and plasticity to foster mental health","volume":"3","author":"Branchi","year":"2024","journal-title":"Neurosci Appl"},{"key":"B9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jad.2012.06.010","article-title":"Cytokines in bipolar disorder: a systematic review and meta-analysis","volume":"144","author":"Munkholm","year":"2013","journal-title":"J Affect Disord"},{"key":"B10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41398-024-02921-z","article-title":"Inflammatory mediators in major depression and bipolar disorder","volume":"14","author":"Poletti","year":"2024","journal-title":"Transl Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bbi.2021.07.014","article-title":"Peripheral levels of C-reactive protein, tumor necrosis factor-\u03b1, interleukin-6, and interleukin-1\u03b2 across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability","volume":"97","author":"Solmi","year":"2021","journal-title":"Brain Behavior Immun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/s2215-0366(16)30370-4","article-title":"C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis","volume":"3","author":"Fernandes","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/360481","article-title":"Cytokines in bipolar disorder: paving the way for neuroprogression","volume":"2014","author":"Barbosa","year":"2014","journal-title":"Neural Plast"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302246","article-title":"IL-27 induces Th17 differentiation in the absence of STAT1 signaling","volume":"195","author":"Peters","year":"2015","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.170","article-title":"Possible roles of IL-12-family cytokines in rheumatoid arthritis","volume":"9","author":"Pope","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00969","article-title":"IL-27, IL-30, and IL-35: A cytokine triumvirate in cancer","volume":"9","author":"Kourko","year":"2019","journal-title":"Front Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.336134","article-title":"Exploring the role of interleukin-27 as a regulator of neuronal survival in central nervous system diseases","volume":"17","author":"Nortey","year":"2022","journal-title":"Neural Regener Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1017\/neu.2021.25","article-title":"Comparison of serum BDNF, IL-1\u03b2, IL-6, TNF-\u03b1, CRP and leucocyte levels in unipolar mania and bipolar disorder","volume":"33","author":"Gorgulu","year":"2021","journal-title":"Acta Neuropsychiatr"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109548118","article-title":"IL-27\u2013producing B-1a cells suppress neuroinflammation and CNS autoimmune diseases","volume":"118","author":"Choi","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2020.97911","article-title":"Interleukin 39: a new member of interleukin 12 family","volume":"45","author":"Lu","year":"2020","journal-title":"Cent Eur J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00479","article-title":"Expanding diversity in molecular structures and functions of the IL-6\/IL-12 heterodimeric cytokine family","volume":"7","author":"Hasegawa","year":"2016","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201546095","article-title":"A novel IL\u201023p19\/Ebi3 (IL\u201039) cytokine mediates inflammation in Lupus\u2010like mice","volume":"46","author":"Wang","year":"2016","journal-title":"Eur J Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.12.001","article-title":"Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder","volume":"116","author":"Brietzke","year":"2009","journal-title":"J Affect Disord"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2017.03.018","article-title":"A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients","volume":"92","author":"Sayana","year":"2017","journal-title":"J Psychiatr Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1186\/s12888-025-07048-z","article-title":"Changes in olfactory function and serum interleukin-6 levels in the acute phase of bipolar I disorder: a longitudinal study","volume":"25","author":"Yang","year":"2025","journal-title":"BMC Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000014419","article-title":"High concentrations of serum interleukin-6 and interleukin-8 in patients with bipolar disorder","volume":"98","author":"Lu","year":"2019","journal-title":"Med (Baltimore)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.psychres.2016.07.027","article-title":"Altered serum levels of TNF-\u03b1, IL-6 and IL-18 in manic, depressive, mixed state of bipolar disorder patients","volume":"244","author":"Luo","year":"2016","journal-title":"Psychiatry Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","article-title":"Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies","volume":"74","author":"Modabbernia","year":"2013","journal-title":"Biol Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900568","article-title":"IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells","volume":"183","author":"Murugaiyan","year":"2009","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/biom14121489","article-title":"Interleukin-27 and autoimmune disorders: a compressive review of immunological functions","volume":"14","author":"Yazdanpanah","year":"2024","journal-title":"Biomolecules"},{"key":"B31","doi-asserted-by":"publisher","first-page":"16547","DOI":"10.1038\/s41598-017-16702-w","article-title":"IL-27, but not IL-35, inhibits neuroinflammation through modulating GM-CSF expression","volume":"7","author":"Casella","year":"2017","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1498288","DOI":"10.3389\/fimmu.2024.1498288","article-title":"Revisiting the role of IL-27 in obesity-related metabolic diseases: safeguard or perturbation","volume":"15","author":"An","year":"2025","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2005.01499.x","article-title":"Hypothalamic\u2010pituitary gonadal axis and immune response imbalance during chronic filarial infections","volume":"10","author":"Mavoungou","year":"2005","journal-title":"Trop Med Int Health"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2015.07.008","article-title":"The biology of interleukin-27 reveals unique pro-and anti-inflammatory functions in immunity","volume":"26","author":"Aparicio-Siegmund","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.21608\/bmfj.2025.410428.2595","article-title":"Serum C-Reactive Protein (CRP) titres in bipolar disorder: systematic review","author":"Ebrahim","year":"2025","journal-title":"Benha Med J"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2007.02.018","article-title":"Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder","volume":"31","author":"Dickerson","year":"2007","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-019-0591-1","article-title":"C-reactive protein is associated with cognitive performance in a large cohort of euthymic patients with bipolar disorder","volume":"26","author":"Millett","year":"2021","journal-title":"Mol Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41467-017-00838-4","article-title":"IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease","volume":"8","author":"Dambuza","year":"2017","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3554","article-title":"Interleukin-35 induces regulatory B cells that suppress autoimmune disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.655114","article-title":"Pathogenesis and function of interleukin-35 in rheumatoid arthritis","volume":"12","author":"Xin","year":"2021","journal-title":"Front Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"776","DOI":"10.21037\/atm-22-2770","article-title":"Interleukin-35 attenuates blood-brain barrier dysfunction caused by cerebral ischemia-reperfusion injury through inhibiting brain endothelial cell injury","volume":"10","author":"Qian","year":"2022","journal-title":"Ann Transl Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.47582\/jompac.1165074","article-title":"IL-35 levels and their association with thyroid function tests in Hashimoto\u2019s thyroiditis","volume":"3","author":"\u0130nan","year":"2022","journal-title":"J Med Palliative Care"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000227","article-title":"Decreased serum levels of IL-27and IL-35 in patients with Graves disease","volume":"64","author":"Saeed","year":"2020","journal-title":"Arch Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1615\/critrevimmunol.2015012558","article-title":"Interleukin 35-producing B cells (i35-Breg): a new mediator of regulatory B-cell functions in CNS autoimmune diseases","volume":"35","author":"Egwuagu","year":"2015","journal-title":"Crit Rev Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110728","article-title":"Human IL-10-producing B cells have diverse states that are induced from multiple B cell subsets","volume":"39","author":"Glass","year":"2022","journal-title":"Cell Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201546095","article-title":"A novel IL-23p19\/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice","volume":"46","author":"Wang","year":"2016","journal-title":"Eur J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.758554","article-title":"Association between interleukin 35 gene single nucleotide polymorphisms and the uveitis immune status in a Chinese Han population","volume":"12","author":"Feng","year":"2021","journal-title":"Front Immunol"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1759397\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:34:46Z","timestamp":1787636086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1759397\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":47,"alternative-id":["10.3389\/fpsyt.2026.1759397"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1759397","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1759397"}}